Back
Black Diamond Therapeutics Stock Price Chart

7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Buy
56
BDTX
Black Diamond Therapeutics
Last Price:
$2.87
Seasonality Move:
-29%
7 Day Trial
ALL ACCESS PASS
$
7

ALERT: Q3 Could Be a Pivotal Quarter for Nasdaq Stocks
Click Here to Download Your FREE Stock Report Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Black Diamond Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.57 | Buy |
20-day SMA: | 2.46 | Buy |
50-day SMA: | 2.19 | Buy |
200-day SMA: | 2.43 | Buy |
8-day EMA: | 2.58 | Buy |
20-day EMA: | 2.47 | Buy |
50-day EMA: | 2.27 | Buy |
200-day EMA: | 2.58 | Buy |
Black Diamond Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.11 | Buy |
Relative Strength Index (14 RSI): | 65.13 | Buy |
Chaikin Money Flow: | 478958 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.36 - 2.58) | Buy |
Bollinger Bands (100): | (1.57 - 2.35) | Buy |
Black Diamond Therapeutics Technical Analysis
Jun 26 | Jun 27 | Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
26 | 27 | 30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Black Diamond Therapeutics Stock
Is Black Diamond Therapeutics Stock a Buy?
-
Black Diamond Therapeutics share price is 2.74 while BDTX 8-day simple moving average is 2.57, which is a Buy signal.
-
The stock price of BDTX is 2.74 while Black Diamond Therapeutics 20-day SMA is 2.46, which makes it a Buy.
-
Black Diamond Therapeutics 50-day simple moving average is 2.19 while BDTX share price is 2.74, making it a Buy technically.
-
BDTX stock price is 2.74 and Black Diamond Therapeutics 200-day simple moving average is 2.43, creating a Buy signal.
BDTX Technical Analysis vs Fundamental Analysis
Buy
56
Black Diamond Therapeutics (BDTX)
is a Buy
Is Black Diamond Therapeutics a Buy or a Sell?
-
Black Diamond Therapeutics stock is rated a BuyThe current Black Diamond Therapeutics [BDTX] share price is $2.74. The Score for BDTX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
Black Diamond Therapeutics Stock Info
Market Cap:
155.8M
Price in USD:
2.74
Share Volume:
778.7K
Black Diamond Therapeutics 52-Week Range
52-Week High:
6.75
52-Week Low:
1.20
Buy
56
Black Diamond Therapeutics (BDTX)
is a Buy
Black Diamond Therapeutics Share Price Forecast
-
What is the Black Diamond Therapeutics stock price today?The Black Diamond Therapeutics stock price is 2.74 USD today.
-
Will BDTX stock go up or go down?Black Diamond Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Black Diamond Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Black Diamond Therapeutics is not overvalued.
Is Black Diamond Therapeutics Stock a Buy?
-
Black Diamond Therapeutics share price is 2.74 while BDTX 8-day exponential moving average is 2.58, which is a Buy signal.
-
The stock price of BDTX is 2.74 while Black Diamond Therapeutics 20-day EMA is 2.47, which makes it a Buy.
-
Black Diamond Therapeutics 50-day exponential moving average is 2.27 while BDTX share price is 2.74, making it a Buy technically.
-
BDTX stock price is 2.74 and Black Diamond Therapeutics 200-day simple moving average is 2.58, creating a Buy signal.
Fundamental Analysis of Black Diamond Therapeutics
Is Black Diamond Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.08 per share, an increase this year of $1.53 per share, and a decrease next year of $0.97 per share.
Technical Analysis of Black Diamond Therapeutics
Should I short Black Diamond Therapeutics stock?
-
BDTX Moving Average Covergence Divergence (MACD) indicator is 0.11, suggesting Black Diamond Therapeutics is a Buy
-
Black Diamond Therapeutics Relative Strength Index (RSI) is 65.13, which suggest Black Diamond Therapeutics is overbought
-
The Bollinger Bands (25) for Black Diamond Therapeutics is (2.36 - 2.58), which suggest Black Diamond Therapeutics is a Buy
-
The Bollinger Bands (100) for Black Diamond Therapeutics is (1.57 - 2.35), which suggest Black Diamond Therapeutics is a Buy
* Black Diamond Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.